Otto Bock Healthcare Products
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Otto Bock Healthcare Products sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Otto Bock Healthcare Products: 5 sponsored US clinical trials, 1 recruiting.
Otto Bock Healthcare Products sponsors 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 3 completed. The most-studied condition in this pipeline is Congenital Amputation of Lower Limb, with 1 trials.
Upper-quartile sponsor footprint
Otto Bock Healthcare Products sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
5 total, page 1 of 1
C-Brace Prospective Registry
NCT04640584
Assessing Outcomes With Microprocessor Knee Utilization in a K2 Population
NCT04784429
Feasibility Study to Evaluate a New Energy Storage and Return Prosthetic Foot
NCT04239222
Clinical Trial Comparing C-Brace to Knee Ankle Foot Orthosis (KAFO)/Stance Control Orthosis (SCO)
NCT03906656
EmPOWERing Active Seniors With Energy
NCT02958553
Therapeutic Areas
What is open in the Otto Bock Healthcare Products pipeline
1 recruiting of 5 indexed (20% open); 3 completed (60%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Congenital Amputation of Lower Limb (1 trial), 4 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Otto Bock Healthcare Products: open-pipeline peers nationwide
Peers matched on 5 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
Otto Bock Healthcare Products sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 trials (± recruiting share)
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Align Technology · 20% recruiting · 5 trials
- AltruBio · 20% recruiting · 5 trials
- Alvernia University · 20% recruiting · 5 trials
- Amazentis · 20% recruiting · 5 trials
Related
What to do with this Otto Bock Healthcare Products page
5 registered trials is a research-attention snapshot, not an endorsement of Otto Bock Healthcare Products or any single study.
- 1 of Otto Bock Healthcare Products's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Congenital Amputation of Lower Limb is the condition Otto Bock Healthcare Products studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Congenital Amputation of Lower Limb trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Otto Bock Healthcare Products pipeline card: 5 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.